Cargando…

The treatment choices of abdominal aortic aneurysm patients in China in the era of value-based healthcare

BACKGROUND: Endovascular aneurysm repair (EVAR) is often seen as the first choice treatment for patients with abdominal aortic aneurysm (AAA), particularly high-risk patients, yet the long-term survival rate and improvement in quality of life are still unclear. In order to seek the value of EVAR to...

Descripción completa

Detalles Bibliográficos
Autores principales: Duan, Liren, Xin, Wei, Li, Shenli, Zhao, Lin, Xin, Shijie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9746798/
https://www.ncbi.nlm.nih.gov/pubmed/36523360
http://dx.doi.org/10.3389/fcvm.2022.961830
_version_ 1784849444048470016
author Duan, Liren
Xin, Wei
Li, Shenli
Zhao, Lin
Xin, Shijie
author_facet Duan, Liren
Xin, Wei
Li, Shenli
Zhao, Lin
Xin, Shijie
author_sort Duan, Liren
collection PubMed
description BACKGROUND: Endovascular aneurysm repair (EVAR) is often seen as the first choice treatment for patients with abdominal aortic aneurysm (AAA), particularly high-risk patients, yet the long-term survival rate and improvement in quality of life are still unclear. In order to seek the value of EVAR to the entire healthcare field, we conducted a retrospective study to evaluate whether the improvement EVAR can truly bring to the quality of medical care in the era of value-based healthcare. METHODS: We included AAA patients who underwent surgical treatment in the Department of Vascular Surgery, First Hospital of China Medical University, from January 1, 2004, to December 31, 2019 and evaluated surgery procedure data, short-term and long-term mortality, complications, prognoses, and medical costs. RESULTS: We analyzed 507 patients with AAA who underwent open repair (n = 232) or EVAR (n = 275) over a 15-year period. The operative time, blood loss, blood transfusion rate, and postoperative length of hospital stay of the EVAR group is significantly lower than which of the open repair group. Meanwhile, neither short-term nor long-term mortality rates shows significant differences between the two groups. On the other hand, the complication rate of the EVAR group was significantly higher than that of the open repair group. Lastly, the total cost of EVAR was significantly higher than that of open repair. CONCLUSION: Existing evidence suggests that EVAR improves neither short-term nor long-term survival rate compared with open surgery. In contrast, the complication rate and the reintervention rate in the EVAR group were higher than those in the open surgery group. Moreover, the cost of EVAR and that paid by medical insurance were higher than those for open surgery. For patients with a long-life expectancy, in order to ensure that patients receive appropriate and effective care, surgeons should choose a suitable method that considers both the quality of medical care as well as the expense accordingly.
format Online
Article
Text
id pubmed-9746798
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-97467982022-12-14 The treatment choices of abdominal aortic aneurysm patients in China in the era of value-based healthcare Duan, Liren Xin, Wei Li, Shenli Zhao, Lin Xin, Shijie Front Cardiovasc Med Cardiovascular Medicine BACKGROUND: Endovascular aneurysm repair (EVAR) is often seen as the first choice treatment for patients with abdominal aortic aneurysm (AAA), particularly high-risk patients, yet the long-term survival rate and improvement in quality of life are still unclear. In order to seek the value of EVAR to the entire healthcare field, we conducted a retrospective study to evaluate whether the improvement EVAR can truly bring to the quality of medical care in the era of value-based healthcare. METHODS: We included AAA patients who underwent surgical treatment in the Department of Vascular Surgery, First Hospital of China Medical University, from January 1, 2004, to December 31, 2019 and evaluated surgery procedure data, short-term and long-term mortality, complications, prognoses, and medical costs. RESULTS: We analyzed 507 patients with AAA who underwent open repair (n = 232) or EVAR (n = 275) over a 15-year period. The operative time, blood loss, blood transfusion rate, and postoperative length of hospital stay of the EVAR group is significantly lower than which of the open repair group. Meanwhile, neither short-term nor long-term mortality rates shows significant differences between the two groups. On the other hand, the complication rate of the EVAR group was significantly higher than that of the open repair group. Lastly, the total cost of EVAR was significantly higher than that of open repair. CONCLUSION: Existing evidence suggests that EVAR improves neither short-term nor long-term survival rate compared with open surgery. In contrast, the complication rate and the reintervention rate in the EVAR group were higher than those in the open surgery group. Moreover, the cost of EVAR and that paid by medical insurance were higher than those for open surgery. For patients with a long-life expectancy, in order to ensure that patients receive appropriate and effective care, surgeons should choose a suitable method that considers both the quality of medical care as well as the expense accordingly. Frontiers Media S.A. 2022-11-29 /pmc/articles/PMC9746798/ /pubmed/36523360 http://dx.doi.org/10.3389/fcvm.2022.961830 Text en Copyright © 2022 Duan, Xin, Li, Zhao and Xin. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Cardiovascular Medicine
Duan, Liren
Xin, Wei
Li, Shenli
Zhao, Lin
Xin, Shijie
The treatment choices of abdominal aortic aneurysm patients in China in the era of value-based healthcare
title The treatment choices of abdominal aortic aneurysm patients in China in the era of value-based healthcare
title_full The treatment choices of abdominal aortic aneurysm patients in China in the era of value-based healthcare
title_fullStr The treatment choices of abdominal aortic aneurysm patients in China in the era of value-based healthcare
title_full_unstemmed The treatment choices of abdominal aortic aneurysm patients in China in the era of value-based healthcare
title_short The treatment choices of abdominal aortic aneurysm patients in China in the era of value-based healthcare
title_sort treatment choices of abdominal aortic aneurysm patients in china in the era of value-based healthcare
topic Cardiovascular Medicine
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9746798/
https://www.ncbi.nlm.nih.gov/pubmed/36523360
http://dx.doi.org/10.3389/fcvm.2022.961830
work_keys_str_mv AT duanliren thetreatmentchoicesofabdominalaorticaneurysmpatientsinchinaintheeraofvaluebasedhealthcare
AT xinwei thetreatmentchoicesofabdominalaorticaneurysmpatientsinchinaintheeraofvaluebasedhealthcare
AT lishenli thetreatmentchoicesofabdominalaorticaneurysmpatientsinchinaintheeraofvaluebasedhealthcare
AT zhaolin thetreatmentchoicesofabdominalaorticaneurysmpatientsinchinaintheeraofvaluebasedhealthcare
AT xinshijie thetreatmentchoicesofabdominalaorticaneurysmpatientsinchinaintheeraofvaluebasedhealthcare
AT duanliren treatmentchoicesofabdominalaorticaneurysmpatientsinchinaintheeraofvaluebasedhealthcare
AT xinwei treatmentchoicesofabdominalaorticaneurysmpatientsinchinaintheeraofvaluebasedhealthcare
AT lishenli treatmentchoicesofabdominalaorticaneurysmpatientsinchinaintheeraofvaluebasedhealthcare
AT zhaolin treatmentchoicesofabdominalaorticaneurysmpatientsinchinaintheeraofvaluebasedhealthcare
AT xinshijie treatmentchoicesofabdominalaorticaneurysmpatientsinchinaintheeraofvaluebasedhealthcare